For Blood Cancer Awareness Month, Dr. Guenther Koehne shares why immunotherapy is making this a promising time for people with blood cancers.
|Articles|April 21, 2015
Dr. Primo Lara Discusses Emerging Therapies in Kidney Cancer
Primo Neary Lara Jr., associate director of Translational Research at the UC Davis Comprehensive Cancer Center, discusses emerging therapies for patients with kidney cancer.
Advertisement
Primo Neary Lara Jr., associate director of Translational Research and co-leader of the Cancer Therapeutics Program at UC Davis Comprehensive Cancer Center, discusses emerging therapies for patients with kidney cancer.
Advertisement
Related to this article
In the latest installment of CURE's "Text a Survivor" series, Brad Moore answers some of the most common questions people have about living with and beyond a colorectal cancer diagnosis.
Researchers are studying whether combining CAR-T cell therapy with targeted drugs could help children with high-risk leukemia, including infants whose cancer may be more likely to return after treatment.
Advertisement
Advertisement
Trending on CURE
1
Could a Genomic Test Spare You Extra Years of Hormone Therapy?
2
My Sister and I Share a BRCA2 Mutation. We Didn’t Make the Same Choices
3
I’m Jealous of the World — and Grateful I Got to Be Part of It
4
We Eat Bagels Before Cancer Treatment. Here’s Why.
5